CC
ELV icon

Claybrook Capital’s Elevance Health ELV Stock Holding History

Claybrook Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-712
Closed -$272K – 159
2021
Q2 		$272K Buy
+712
New +$272K 0.09% 143
2019
Q1 		– Sell
-3
Closed -$1K – 256
2018
Q4 		$1K Buy
+3
New +$825 ﹤0.01% 690

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Claybrook Capital's ELV Position: Q3 2021 in Review

Claybrook Capital sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 712 shares — an estimated $272K sold.

Claybrook Capital first reported a position in ELV in Q4 2018 and held it in 2 quarters. The position peaked at $272K in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Claybrook Capital reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
  • Claybrook Capital sold 712 Elevance Health shares in Q3 2021, an estimated $272K.
  • Claybrook Capital first reported a position in Elevance Health in Q4 2018 and held it in 2 quarters.
  • Claybrook Capital's Elevance Health position peaked at $272K in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Claybrook Capital's 13F filing for Q3 2021, filed 15 Nov 2021.